Genetic knockdown and pharmacological inhibition of CPS1 significantly reduced the tumor burden and metastasis in mice with the spontaneous (KrasG12D/+; p53-/-) and induced metastatic lung cancer. This evidence concerns the gene TP53 and neoplasm.